Our Story
1986
Aurobindo Pharma, Ltd. | Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small, highly committed group of professionals. It commenced operations in 1988-89 with a single unit manufacturing semi synthetic penicillins (SSPs) at Pondicherry. Company became a public venture in 1992.
2011
The formation of the Injectable Division. AuroMedics mission is to develop and bring as many injectable products to the US institutional market as possible providing a consistent and reliable supply, at a fair price and of the highest quality.
2013
Commenced marketing specialty injectables to fund the development in USA through AuroMedics. Building capabilities in Penem, Oncology & Biocatalysis
2021
A strategic decision was made to separate our specialty business under the subsidiary Eugia Pharma Specialties Limited. This move aimed to create a dedicated entity focused on specialty products, enabling better alignment with market demands and enhancing growth opportunities in this segment
2022
AuroMedics changed to Eugia US, giving us dedicated resources enabling us to be nimbler and more focused to meet market and customer demands, including dedicated leadership, manufacturing facilities, R&D capabilities, product selection teams, logistics, quality control, business development and supply chain
2025
Coming Soon.
Manufacturing Facilities
& U.S. Headquarters
Shamirpet, Hyderabad
Total Area | 60,600 Sq. Ft
Built-up Area | 18,100S q. Ft
6 Manufacturing Lines:
• Solutions & Lyophilized Powders
• Vials & Syringes
We serve patients in over 120 countries through a robust distribution network, providing trusted pharmaceutical products across continents.
Driven by knowledge and compassion, our 4000+ global workforce brings together deep scientific expertise and an unwavering commitment to patient care.
With over 250 product approvals from top international regulatory bodies, our portfolio reflects global standards in efficacy, safety, and compliance.
Global Presence
